Uptake in regions of a highly parcellated brain atlas indicated robust agreement between early phases of tau-PET and amyloid-PET, especially in signature regions of significant neuronal damage in AD and PSP. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.